HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study.

AbstractOBJECTIVE:
The purpose of this study was to estimate the outcomes of uterine embolization and hysterectomy for uterine leiomyomas. Study design This was a multicenter prospective study of patients who were treated with embolization (n=102 patients) and hysterectomy (n=50 patients) for leiomyomas. Changes in symptoms, complications, and quality of life were measured. The data analysis included linear and logistic regression, the Student t and paired t test, Fisher's exact test, and chi-squared test.
RESULTS:
For patients who underwent embolization, there were marked reductions in blood loss scores (P <.001) and menorrhagia questionnaire scores (P <.001) compared with baseline. At 12 months, a larger proportion of the patients who had undergone hysterectomy experienced improved pelvic pain (P=.021). Both groups had marked improvement in other symptoms and quality of life scores, with no difference between groups. Complications were more frequent in patients who underwent hysterectomy (50% vs 27.5%; P=.01).
CONCLUSION:
Both procedures substantially improved symptoms for most patients, with an advantage for hysterectomy at 12 months for pelvic pain. Serious complications were infrequent in both groups.
AuthorsJames B Spies, Jay M Cooper, Robert Worthington-Kirsch, John C Lipman, Benjie B Mills, James F Benenati
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 191 Issue 1 Pg. 22-31 (Jul 2004) ISSN: 0002-9378 [Print] United States
PMID15295340 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Arteries
  • Embolization, Therapeutic (adverse effects)
  • Female
  • Health Status Indicators
  • Humans
  • Hysterectomy (adverse effects)
  • Leiomyoma (blood supply, surgery, therapy)
  • Logistic Models
  • Microspheres
  • Middle Aged
  • Quality of Life
  • Treatment Outcome
  • Uterine Neoplasms (blood supply, surgery, therapy)
  • Uterus (blood supply)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: